Kat Kozyrytska | Founder
Cell Therapy Manufacturability Program

Kat Kozyrytska, Founder, Cell Therapy Manufacturability Program

Appearances:



Advanced Therapies USA 2025 - Day 2 @ 11:00

Roundtable 11: Analytical cell therapy bio-bank for cell therapy manufacturability

Kat Kozyrytska, Founder, Cell Therapy Manufacturability Program

Advanced Therapies USA 2025 - Day 2 @ 14:05

Panel Discussion: Point-of-care manufacturing

Moderator: Ashley Krull, Associate Director, Cell Therapy Manufacturing and Engineering, The Ohio State University Wexner Medical Center
Stephan Kadauke, Associate Professor of Clinical Pathology and Lab Medicine, The Children's Hospital of Philadelphia
Patrick Gailliot, Sr. Director, Patient Operations, Abeona Therapeutics
Nan Zhang, Chief, Cell Therapy Manufacturing Section, Center for Cellular Engineering, National Institutes of Health
Stephanie Heathman, Business Development Lead, Opie Jones Foundation
Kat Kozyrytska, Founder, Cell Therapy Manufacturability Program
Priya Baraniak, Chief Commercial and Development Officer, Pluristyx, Inc.
Therese Choquette, Head of Analytical and Translational Sciences, Tigen Pharma
last published: 19/Aug/25 17:25 GMT

back to speakers

Get Involved with the Advanced Therapies Congress

 

To sponsor or exhibit

Natasha Bangle
natasha.bangle@terrapinn.com
+44 20 3545 5515

 

To speak

Chris Shanks
chris.shanks@terrapinn.com
+44 20 8152 7604